These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23334131)

  • 1. Unusual uptake of 18FDG by a hepatic adenoma.
    Fosse P; Girault S; Hoareau J; Testard A; Couturier O; Morel O
    Clin Nucl Med; 2013 Feb; 38(2):135-6. PubMed ID: 23334131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT.
    Sanli Y; Bakir B; Kuyumcu S; Ozkan ZG; Gulluoglu M; Bilge O; Turkmen C; Mudun A
    Clin Nucl Med; 2012 Jul; 37(7):697-8. PubMed ID: 22691518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor.
    Song L; Zhang W; Zhang Y
    Clin Nucl Med; 2014 Jul; 39(7):662-4. PubMed ID: 24686215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.
    Lim D; Lee SY; Lim KH; Chan CY
    World J Gastroenterol; 2013 Jul; 19(27):4432-6. PubMed ID: 23885159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
    Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
    Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of advanced colorectal adenoma.
    Gollub MJ; Grewal RK; Panu N; Thipphavong S; Sohn M; Zheng J; Moskowitz CS
    Clin Radiol; 2014 Jun; 69(6):611-8. PubMed ID: 24581969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature.
    Kitapci MT; Akkaş BE; Gullu I; Sokmensuer C
    Ann Nucl Med; 2010 Aug; 24(7):549-53. PubMed ID: 20414751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-MDP- and 18F-FDG-avid metastatic liver lesion: the similarities and differences between 2 modalities.
    Aras M; Dede F; Ones T; Dane F; Inanir S; Erdil TY; Turoglu HT
    Clin Nucl Med; 2012 Apr; 37(4):380-1. PubMed ID: 22391711
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
    Pant V; Sen IB; Soin AS
    Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
    Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
    Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT of Bronchial Mucous Gland Adenoma.
    Cho J; Eo JS; In KH; Kim CH; Choe JG
    Clin Nucl Med; 2016 Feb; 41(2):e118-9. PubMed ID: 26252327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomas.
    Grassetto G; Marzola MC; Chondrogiannis S; Maffione AM; Rampin L; Galeotti F; Colletti PM; Rubello D
    Clin Nucl Med; 2014 Feb; 39(2):156-9. PubMed ID: 24321829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.
    Hwang JP; Woo SK; Yoon SY; Jeong SY
    Ann Nucl Med; 2015 Feb; 29(2):157-63. PubMed ID: 25358843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.
    Farquharson AL; Chopra A; Ford A; Matthews S; Amin SN; De Noronha R
    Colorectal Dis; 2012 Feb; 14(2):e56-63. PubMed ID: 21831171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.
    Treglia G; Calcagni ML; Rufini V; Leccisotti L; Meduri GM; Spitilli MG; Dambra DP; De Gaetano AM; Giordano A
    Colorectal Dis; 2012 Feb; 14(2):174-80. PubMed ID: 21689289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
    Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
    Koolen BB; Vegt E; Rutgers EJ; Vogel WV; Stokkel MP; Hoefnagel CA; Fioole-Bruining A; Vrancken Peeters MJ; Valdés Olmos RA
    Ann Nucl Med; 2012 Jan; 26(1):86-91. PubMed ID: 21953212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
    Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F
    Clin Nucl Med; 2009 Oct; 34(10):659-65. PubMed ID: 19893396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.